Immunohistochemical Markers and TILs Evaluation for Endometrial Carcinoma.
Valentina Elisabetta BounousAnnamaria FerreroPaola CampisiLuca FusoJeremy Oscar Smith Pezua SanjinezSabrina ManasseroGiovanni De RosaNicoletta BigliaPublished in: Journal of clinical medicine (2022)
= 0.01) Conclusions: The prognostic model based on IHC markers could potentially be a valid and applicable alternative to the TCGA one. The PgR determination could represent an additional prognostic factor for EC.